Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 167 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HPV Vaccination Clear all

Conditions: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally Advanced Oropharyngeal Carcinoma, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions: Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101, Pembrolizumab, Computed Tomography, FDG-Positron Emission Tomography, Biospecimen Collection, Biopsy; Biological · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Infections, Papillomavirus
Interventions: Data collection; Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 9 Years to 25 Years · Female only
Enrollment: 1,516 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Human Papilloma Virus, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination, Meningitis, Meningococcal, Communication, Satisfaction
Interventions: AFIX Only, AFIX+ Provider Communication Training; Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Human Papillomavirus-Related Cervical Carcinoma
Interventions: Non-Interventional Study; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Vaccine Preventable Diseases, Meningococcal Disease, Human Papillomavirus, Pertussis, Influenza
Interventions: Point-of-Care Prompt; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 11 Years to 18 Years
Enrollment: 7,040 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 22
States / cities: Little Rock, Arkansas • Wilmington, Delaware • Gainesville, Florida + 12 more

Conditions: HPV-Related Carcinoma
Interventions: brief negotiated mobile application; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 9 Years to 17 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Human Papilloma Virus
Interventions: Comprehensive Vaccine Promotion Package; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 11 Years to 12 Years
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 6
States / cities: Canton, Georgia • Duluth, Georgia • Lawrenceville, Georgia + 3 more

Conditions: Human Papilloma Virus
Interventions: Usual Care, ECA-HPV App with Clinic Notification and Adolescent Functions Disabled, ECA-HPV App with Clinic Notification Function Enabled, ECA-HPV App with Adolescent Function Enabled, ECA-HPV App with Clinic Notification and Adolescent Functions Enabled; Behavioral
Lead sponsor: Tufts Medical Center; Other
Eligibility: 8 Years to 12 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Immunization Program, School Health Services, HPV Vaccines
Interventions: Modified Vaccine Consent Form; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Not listed
Enrollment: 3,417 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: HPV Vaccination
Interventions: Microvideos: HPV Vaccination Education; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 26 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: HPV Infection, Preventive Health Services
Interventions: Physician Communication 2 Virtual (PCOM2-virtual), Physician Communication Standard (PCOM-standard); Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 9 Years to 17 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Aurora, Colorado • Wichita, Kansas

Conditions: Immunization, Vaccination
Interventions: STOP-HPV performance feedback intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 11 Years to 17 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Itasca, Illinois

Conditions: Human Papilloma Virus, Cervical Dysplasia
Interventions: Educational video; Other
Lead sponsor: George Washington University; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Human Papillomavirus Vaccines
Interventions: Project Voice, HPV Informational Video; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 11 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: HPV Vaccination
Interventions: General HPV Vaccine Health Messaging, Culturally Targeted HPV Vaccine Health Messaging; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 265 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: HPV Vaccination Status
Interventions: Tailored educational materials, Untailored educational materials, Survey-only; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 75 Years
Enrollment: 1,294 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Human Papilloma Virus
Interventions: Communication training, financial Incentive; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 9 Years to 12 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: HPV-associated Cancer
Interventions: HPV app intervention; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 11 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Vaccination Hesitancy, Human Papillomavirus Vaccination, Vaccine Refusal
Interventions: Argument inoculation messages, Simple forewarning message; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 523 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HPV
Interventions: (Intervention) Recommending HPV vaccine for patients 9-10 years of age, (Control) Recommending HPV vaccine for patients 11-12 years of age; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 9 Years to 13 Years
Enrollment: 62,272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Los Angeles, California • Aurora, Colorado

Conditions: HPV Vaccine, HPV
Interventions: Online survey, Focus groups or Individual Interviews, Interviews; Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 155 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: HPV Vaccination Intent
Interventions: Default-style LLM chatbot, Conversational-style LLM chatbot, Public health informational materials; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 930 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HPV, Vaccine-Preventable Diseases
Interventions: vaccination game; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 11 Years to 14 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chandler, Arizona

Conditions: N/A - Healthy Subjects
Interventions: short videos related to HPV and the HPV vaccine, CDC HPV Fact Sheet; Other
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years to 26 Years
Enrollment: 123 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: East Lansing, Michigan

Search by objective public record fields.

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination

High and Low Resource Interventions to Promote HPV Vaccines

Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in Northeast Florida

Testing the Use of Prompts to Increase Adolescent Immunization Rates

Integrating Primary & Secondary Interventions for Cervical Cancer Prevention in Primary Care Settings

PreTeenVax Evaluation

Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial

A School Health Center Intervention to Increase Adolescent Vaccination

Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors

PCOM2 - The Physician Communication Intervention, Version 2.0

The STOP-HPV Trial 2: Performance Feedback Intervention

Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial

Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI

Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination

Impact of Financial Incentives

Multi-Level Communication Strategies for HPV Vaccination in Hmong Adolescents

Testing the Persuasiveness of Pro-inoculation Arguments

The HPV 9-10 Trial: Early Initiation of HPV Vaccination

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

Conversations With AI Chatbots Increase Short-Term Vaccine Intentions But Do Not Outperform Standard Public Health Messaging

Playing Game to Learn About Children's Vaccine Project

Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion